Document Detail


Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations.
MedLine Citation:
PMID:  12902099     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The aim of the present study was to ascertain the percentage of left apical myocardial apoptosis in three-vessel coronary artery bypass grafting patients quantitatively and the impact of ischemic preconditioning. METHODS: Twenty-one patients with three-vessel disease who had elective coronary artery bypass grafting were randomized in a ratio of 2:1 to ischemic preconditioning (n = 14) or a control group (n = 7). The ischemic preconditioning protocol was established by two cycles of ascending aorta occlusion for 2 minutes followed by 3 minutes of reperfusion. Myocardial samples from the apex of the left ventricle were taken using a Tru-Cut needle before aortic cross-clamping and immediately after declamping. The percentage of apoptosis was analyzed by TUNEL methods. Data on hemodynamics and biochemical markers were collected. RESULTS: Low levels of myocardial apoptosis were found before the operation (0.01% +/- 0.00%). During the early reperfusion period, the percentage of myocardial apoptotic cells significantly increased (0.15% +/- 0.05%, p = 0.008). Ischemic preconditioning significantly improved cardiac index and right ventricular ejection fraction recovery after the operation (p = 0.036 and 0.001 respectively, repeated measure) but had no effect on myocardial apoptosis before and after the operation (0.01 +/- 0.00 versus 0.01 +/- 0.00, p = 0.658 and 0.12% +/- 0.04% versus 0.23% +/- 0.14%, p = 0.302). CONCLUSIONS: Cardioplegic myocardial ischemia during open heart operation was associated with induction of cardiomyocyte apoptosis in humans. Attenuation of postoperative cardiac dysfunction by ischemic preconditioning appeared to be independent of apoptosis.
Authors:
Zhong-Kai Wu; Jari Laurikka; Antti Saraste; Ville Kytö; Erkki J Pehkonen; Timo Savunen; Matti R Tarkka
Related Documents :
9722349 - Ischaemic preconditioning: a clinical perspective.
3947209 - A family study of the association of increased ventricular size with schizophrenia.
11082409 - Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning.
8419009 - Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity durin...
20098279 - Sildenafil citrate augments myocardial protection in heart transplantation.
16142599 - Cardiac preconditioning during percutaneous coronary interventions.
2525319 - Effects of nicorandil on coronary circulation and myocardial ischemia.
10933379 - Coronary collateral development during chronic ischemia: serial assessment using harmon...
12204509 - Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  76     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-08-06     Completed Date:  2003-09-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  528-34     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiac Surgery, Department of Surgery, Tampere University Hospital, Tampere, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Apoptosis / physiology*
Biological Markers / analysis
Cardiopulmonary Bypass
Coronary Artery Bypass / methods*
Coronary Disease / surgery
Creatine Kinase / blood
Female
Follow-Up Studies
Hemodynamics
Humans
In Situ Nick-End Labeling
Ischemic Preconditioning, Myocardial*
Male
Middle Aged
Myocardial Reperfusion Injury / prevention & control*
Myocardium / cytology,  pathology*
Preoperative Care / methods
Probability
Reference Values
Risk Assessment
Treatment Outcome
Troponin I / blood
Ventricular Function, Left
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Troponin I; EC 2.7.3.2/Creatine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impaired oxygenation and increased hemolysis after cardiopulmonary bypass in patients with glucose-6...
Next Document:  Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients.